Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET BRAIN
2018-004875-11Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of erenumab in episodic migraine, migraine, sponsored by Novartis. Started Jan 2021; status: completed.
02
Drugs
erenumab
03
Conditions
episodic migrainemigraine
Beyond the preview
Go deeper on 2018-004875-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004875-11.